Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
about
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysisTemporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in UgandaTrends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western KenyaFive years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll outEffect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western KenyaThe role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan AfricaMolecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia.Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions.Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in UgandaTemporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial GuineaCreative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa.Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in
P2860
Q26795623-204C36D1-50B7-484C-978E-20D0117B198AQ28125904-06533F12-4A71-4E30-BF34-669869867C40Q28125907-43F2CCE1-5BCB-4F11-A321-FAB8D0D4BE25Q28125918-6A56186C-B983-4EEC-BBD3-04DDAC24B313Q28477515-9309FFEB-FCF7-4F9F-A03B-AEAD3E76A722Q28477925-3416BDA5-C4BB-4F3F-B7C3-6EA5955279CFQ28487960-E695D0CF-5542-427F-9F7A-05D47F281385Q28553597-3E9F9228-D471-4F4B-A43C-919132C363D9Q33721915-8AA1F135-1DAA-4D6A-AFA5-285ED532117CQ33950981-07154BDF-78EC-4A27-B36D-FA7417DCF386Q34488950-F99764B5-0043-4277-B158-6471779CF1A2Q35190340-962B9BC8-88A9-42A7-8E51-731BECB39599Q35960861-6FFE94C0-871D-47C2-B99B-9656D6C78E1FQ36077922-6B440E8F-3D42-4060-AF82-F5FF808F82D1Q36094714-6B486745-E123-4817-AEA2-5335BD45A440Q36752392-B770C0E0-546F-4470-BC3E-E0D6B01D456FQ36794459-56FFED97-E5FE-49F1-9484-990EA9B6748AQ41157564-F5211788-4FAA-415D-A0D1-3F0E70FAA7CDQ46728060-63DF64A3-03F5-4D8D-9980-83C6093A753EQ48023089-E1B8DF5B-C595-4936-BB24-EC578CFE4C7CQ56440042-0A8188F8-9C3F-4D5E-87D4-4190822E30AC
P2860
Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@ast
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@en
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@nl
type
label
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@ast
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@en
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@nl
prefLabel
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@ast
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@en
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@nl
P2093
P2860
P356
P1433
P1476
Increased prevalence of the pf ...... 581 and 613 in Kisumu, Kenya.
@en
P2093
Fredrick L Eyase
Hoseah M Akala
Maroya D Spalding
Norman C Waters
Rodney L Coldren
Sheryl A Bedno
William J Moss
P2860
P2888
P356
10.1186/1475-2875-9-338
P577
2010-11-24T00:00:00Z
P5875
P6179
1023087309